Evidence map›Paper›PMID 33122852›Full record

ArticleNature immunology2021

Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.

Philippos Demetriou, Enas Abu-Shah, Salvatore Valvo, Sarah McCuaig, Viveka Mayya, Audun Kvalvaag, Thomas Starkey, Kseniya Korobchevskaya, Lennard Y W Lee, Matthias Friedrich and 13 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Philippos Demetriou *Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Enas Abu-Shah *Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-5033-8171
Salvatore ValvoKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Sarah McCuaigKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2304-7739
Viveka MayyaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Audun KvalvaagKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Thomas StarkeyInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID http://orcid.org/0000-0002-6692-9563
Kseniya KorobchevskayaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Lennard Y W LeeInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.ORCID http://orcid.org/0000-0002-8993-8438
Matthias FriedrichKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Elizabeth MannKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8339-2094
Mikhail A KutuzovSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3386-4350
Matteo MorottiOvarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1790-1185
Nina WietekOvarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Heather RadaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Shamsideen YusufKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Jehan AfroseKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Anastasios SiokisDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-4695-0354
Oxford IBD Cohort Investigators
Michael Meyer-HermannDepartment of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany.
Ahmed Ashour AhmedOvarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
David DepoilKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Michael L DustinKennedy Institute of Rheumatology, University of Oxford, Oxford, UK. michael.dustin@kennedy.ox.ac.uk.ORCID http://orcid.org/0000-0003-4983-6389

Funding

U.T. M. D. Anderson Cancer Center SPORE in Ovarian CancerP50CA217685 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C, SOOD, ANIL K · 2017 to 2021
$7.9M
Medical Research Council MC_PC_MR/S025952/1Medical Research Council MC_UU_00008/7Medical Research Council MC_UU_12010/7Medical Research Council MR/S036377/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33122852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.